image
Healthcare - Biotechnology - NASDAQ - US
$ 22.56
0.0443 %
$ 3.78 B
Market Cap
16.47
P/E
Price Target Average
7.65%
Revenue Forecast Estimate
15.00%
EBIT Estimate
--32.79%
Net Income Estimate
17.66%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets ACADIA Pharmaceuticals Inc.
image
Wall Street analysts predict an average 1-year price target for ACAD of $24.3 , with forecasts ranging from a low of $20 to a high of $32 .
ACAD Lowest Price Target Wall Street Target
20 USD -11.35%
ACAD Average Price Target Wall Street Target
24.3 USD 7.65%
ACAD Highest Price Target Wall Street Target
32 USD 41.84%
Price
Max Price Target
Min Price Target
Average Price Target
3232303028282626242422222020181816161414Sep '24Sep '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26Jul '26Jul '26
REVENUE FORECAST

Revenue Forecast Chart ACAD

image
$1.8b$1.8b$1.6b$1.6b$1.4b$1.4b$1.2b$1.2b$1.0b$1.0b$800.0m$800.0m$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart ACAD

image
$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart ACAD

image
$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029